Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
786.00    -6.00 (-0.76%)
Bid:
786.00
Ask:
790.00
Spread: 4.00 (0.509%)
Market Cap: £7.86b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Half-year Report

29 Nov 2021 14:38

RNS Number : 9227T
Wise PLC
29 November 2021
 

Wise plc

29 November 2021

 

Release of unaudited historic financial information

 

Wise is today releasing selected historic consolidated financial statements on an unaudited half yearly basis for the year ended 31 March 2021.

 

 

Enquiries

Martin Adams - Head of Owner Relations

martin.adams@wise.com

 

 

Condensed consolidated statement of comprehensive income (unaudited)

 

 

Year ended

Half-year ended

Half-year ended

£m (unless otherwise noted)

31 March 2021

30 September 2020

31 March 2021

Revenue

421.0

192.2

228.8

Cost of sales

(151.7)

(71.8)

(79.9)

Net credit losses on financial assets

(8.8)

(1.2)

(7.6)

Gross profit

260.5

119.2

141.3

Administrative expenses

(217.5)

(97.6)

(119.9)

Interest income from investments and operating assets

1.9

1.0

0.9

Interest expense from operating assets

(3.8)

(1.6)

(2.2)

Other income

3.8

1.1

2.7

Operating profit

44.9

22.1

22.8

Finance expense

(3.8)

(2.1)

(1.7)

Profit before tax

41.1

20.0

21.1

Income tax expense

(10.2)

(5.4)

(4.8)

Profit for the period

30.9

14.6

16.3

Other comprehensive income

Items that may be reclassified to profit or loss:

Fair value (loss)/gain on investments

(3.0)

0.2

(3.2)

Currency translation differences

(3.8)

0.3

(4.1)

Total other comprehensive (loss)/income

(6.8)

0.5

(7.3)

Total comprehensive income for the period

24.1

15.1

9.0

 

 

 

Condensed consolidated statement of financial position (unaudited)

 

 

As at 31 March

As at 30 September

As at 31 March

£m

2020

2020

2021

Non-current assets

Deferred tax assets

32.0

38.7

56.7

Property, plant and equipment

19.1

16.7

24.0

Intangible assets

21.3

24.4

27.5

Trade and other receivables

7.6

8.3

15.1

Total non-current assets

80.0

88.1

123.3

Current assets

Current tax assets

2.1

1.7

1.1

Trade and other receivables

102.6

89.2

81.3

Short-term financial investments

114.1

289.3

737.5

Cash and cash equivalents

2,077.6

2,872.1

3,358.6

Total current assets

2,296.4

3,252.3

4,178.5

Total assets

2,376.4

3,340.4

4,301.8

Non-current liabilities

Deferred tax liabilities

-

-

2.0

Non-current borrowings

59.6

9.0

95.2

Non-current trade and other payables

7.4

9.5

22.6

Total non-current liabilities

67.0

18.5

119.8

Current liabilities

Borrowings

4.2

28.3

3.5

Current tax liabilities

0.7

0.8

2.0

Trade and other payables

2,107.7

3,051.2

3,891.2

Total current liabilities

2,112.6

3,080.3

3,896.7

Total liabilities

2,179.6

3,098.8

4,016.5

Equity

Share capital

9.4

9.4

9.4

Equity merger reserve

111.1

112.0

(8.0)

Share-based payment reserves

63.8

90.0

124.5

Own shares reserve

-

-

-

Other reserves

2.3

2.5

(0.7)

Retained earnings

8.9

26.1

162.6

Currency translation differences

1.3

1.6

(2.5)

Total equity

196.8

241.6

285.3

Total liabilities and equity

2,376.4

3,340.4

4,301.8

 

 

Condensed consolidated statement of cash flows (unaudited)

 

 

 

£m

Year ended

Half-year ended

Half-year ended

31 March 2021

30 September 2020

31 March 2021

Cash flows from operating activities

Cash generated from operations

2,076.3

1,012.0

1,064.3

Interest received

7.6

2.7

4.9

Interest expense paid

(6.0)

(2.7)

(3.3)

Corporate income tax paid

(4.0)

(0.8)

(3.2)

Net cash generated from operating activities

2,073.9

1,011.2

1,062.7

Cash flows from investing activities

Payments for property, plant and equipment

(2.3)

(1.1)

(1.2)

Payment for intangible assets

(20.9)

(10.1)

(10.8)

Payments for financial assets at FVOCI

(723.9)

(222.7)

(501.2)

Proceeds from sale and maturity of financial assets at FVOCI

75.3

41.1

34.2

Net cash used in investing activities

(671.8)

(192.8)

(479.0)

Cash flows from financing activities

Proceeds from issues of shares and other equity

0.9

0.9

-

Proceeds from borrowings

118.6

25.0

93.6

Repayments of borrowings

(90.0)

(50.0)

(40.0)

Payments for lease liabilities

(4.7)

(2.4)

(2.3)

Net cash generated from financing activities

24.8

(26.5)

51.3

Net increase in cash and cash equivalents

1,426.9

791.9

635.0

Cash and cash equivalents at beginning of the period

2,077.6

2,077.6

2,872.1

Effects of exchange rate changes on cash and cash equivalents

(145.9)

2.6

(148.5)

Cash and cash equivalents at end of the period

3,358.6

2,872.1

3,358.6

 

 

Condensed consolidated statement of changes in equity (unaudited)

 

 

£m

Share capital

Equity merger reserve

Share-based payment reserves

Own shares reserve

Other reserves

Retained earnings

Currency translation differences

Total equity

At 1 April 2020

9.4

111.1

63.8

-

2.3

8.9

1.3

196.8

Profit for the period

-

-

-

-

-

14.6

-

14.6

Fair value gain on investments

-

-

-

-

0.2

-

-

0.2

Foreign currency translation differences

-

-

-

-

-

-

0.3

0.3

Total comprehensive income for the period

-

-

-

-

0.2

14.6

0.3

15.1

Share-based employee compensation expense

-

-

18.0

-

-

-

-

18.0

Deferred tax on share-based compensation

-

-

10.8

-

-

-

-

10.8

Share options exercises

-

0.9

(2.6)

-

-

2.6

-

0.9

At 30 September 2020

9.4

112.0

90.0

-

2.5

26.1

1.6

241.6

Profit for the period

-

-

-

-

-

16.3

-

16.3

Fair value loss on investments

-

-

-

-

(3.2)

-

-

(3.2)

Foreign currency translation differences

-

-

-

-

-

-

(4.1)

(4.1)

Total comprehensive income for the period

-

-

-

-

(3.2)

16.3

(4.1)

9.0

Reduction of share capital

-

(120.0)

-

-

-

120.0

-

-

Share-based employee compensation expense

-

-

18.9

-

-

-

-

18.9

Deferred tax on share-based compensation

-

-

15.8

-

-

-

-

15.8

Share options exercises

-

-

(0.2)

-

-

0.2

-

-

At 31 March 2021

9.4

(8.0)

124.5

-

(0.7)

162.6

(2.5)

285.3

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFVSLSLAFIL
Date   Source Headline
26th Aug 20254:21 pmRNSDirector/PDMR Shareholding
21st Aug 20259:15 amRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSNotice of AGM
13th Aug 202511:58 amRNSDirector/PDMR Shareholding
11th Aug 202511:36 amRNSBlock listing Interim Review
11th Aug 202511:00 amRNSDirector/PDMR Shareholding
4th Aug 20252:08 pmRNSDirector/PDMR Shareholding
1st Aug 202512:30 pmRNSDirector/PDMR Shareholding
1st Aug 202512:26 pmRNSTotal Voting Rights
28th Jul 20256:24 pmRNSResults of Court Meetings and EGM
21st Jul 20254:37 pmRNSDirector/PDMR Shareholding
21st Jul 202511:17 amRNSApplication of the UK Takeover Code
21st Jul 20257:08 amRNSStatement pursuant to s 314 of the Companies Act
17th Jul 20252:21 pmRNSDirector/PDMR Shareholding
17th Jul 20257:00 amRNSWise plc Q1 FY26 Trading Update
3rd Jul 20257:26 amRNSPublication of Scheme Circular
3rd Jul 20257:00 amRNSPublication of Scheme Circular
1st Jul 20254:07 pmRNSTotal Voting Rights
26th Jun 202512:55 pmRNSDirector/PDMR Shareholding
19th Jun 20257:00 amRNSAnnual Financial Report
16th Jun 20253:20 pmRNSTotal Voting Rights
11th Jun 20251:24 pmRNSDirector/PDMR Shareholding
9th Jun 20254:12 pmRNSDirector/PDMR Shareholding
5th Jun 20257:00 amRNSResults for the financial year ended 31 March 2025
2nd Jun 20252:20 pmRNSTotal Voting Rights
19th May 20254:19 pmRNSDirector/PDMR Shareholding (Replacement)
19th May 20254:18 pmRNSDirector/PDMR Shareholding (Replacement)
1st May 202510:09 amRNSTotal Voting Rights
22nd Apr 20259:57 amRNSDirector/PDMR Shareholding
17th Apr 20254:14 pmRNSDirector/PDMR Shareholding
15th Apr 20257:00 amRNSQ4FY25 Trading Update
8th Apr 20253:28 pmRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNSWise Capital Markets Day
1st Apr 20254:55 pmRNSTotal Voting Rights
14th Mar 20253:52 pmRNSWise to host Capital Markets Day
7th Mar 20254:24 pmRNSDirector/PDMR Shareholding
3rd Mar 202512:14 pmRNSTotal Voting Rights
3rd Mar 20257:00 amRNSChange of Registered Office
13th Feb 202510:01 amRNSDirector/PDMR Shareholding
10th Feb 20254:46 pmRNSDirector/PDMR Shareholding
10th Feb 20252:38 pmRNSBlock listing Interim Review
5th Feb 20253:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20254:40 pmRNSTotal Voting Rights
27th Jan 20253:28 pmRNSDirector/PDMR Shareholding
20th Jan 20254:24 pmRNSDirector/PDMR Shareholding
16th Jan 20257:00 amRNS3rd Quarter Results
2nd Jan 202511:47 amRNSTotal Voting Rights
3rd Dec 20244:41 pmRNSDirector/PDMR Shareholding
2nd Dec 20243:52 pmRNSTotal Voting Rights
7th Nov 20244:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.